# Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

> **NCT03005379** · PHASE2,PHASE3 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 153 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Fecal Microbiota Therapy (FMT)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03005379
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-15
- **Primary completion:** 2022-08-30
- **Final completion:** 2023-01-31
- **Target enrollment:** 153 (ACTUAL)
- **Why stopped:** Study is terminated for futility per protocol-specified interim analysis and DMC recommendation.
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03005379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03005379, "Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03005379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*